Tirzepatide
Sold under the brand names; Mounjaro & Zepbound and approved for use (depending on the brand) for weight management, blood glucose management and cardiovascular risk reduction.
Tirzepatide is a long-acting GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist that increases insulin sensitivity and secretion, suppresses glucagon secretion, and slows gastric emptying.1
Key Usage Considerations
Oral vs Injectable Treatment
Body Composition
Side Effects
Ending Treatment
References
Metadata
Created:
Last Updated: 2026-01-24
-
https://bnf.nice.org.uk/drugs/tirzepatide/ - 2024-12-04 ↩